First anthrax vaccine developed using recombinant DNA technology- Annual production capacity of up to 10 million doses at GC ...

According to Research by SNS Insider, the U.S. Peptide Therapeutics Market is Set to Reach USD 35.71 Billion by 2032, Supported by Rising Adoption of Precision Biologics and Advances in Peptide ...

A Nobel laureate, he identified an enzyme that cuts DNA, laying the groundwork for milestones in scientific research and ...

Chaudhary Sarwan Kumar Himachal Pradesh Krishi Vishvavidyalaya, Palampur, successfully concluded a two-day workshop on ...

An Australian biotech firm says it has successfully used precision fermentation to reproduce the most vital proteins in human ...

The protein, reverse transcriptase, has become an essential tool for making DNA copies of RNA.

Australian startup All G has secured A$10M ($6.6M) and signed a joint venture with Armor Protéines to expand production of ...

FDA grants a Type A meeting on December 18th to review new and expanded datasets submitted by Saol to help identify a feasible path forward without the need for an additional clinical trial ROSWELL, ...

Explore trends before investing – request a sample report today! A central growth driver for the Norway Aquaculture Vaccines Market is the nation’s strict sustainability standards, which prioritize ...

Oxford Nanopore Technologies, the company delivering a new generation of molecular sensing technology based on nanopores, today announces the appointment of Francis Van Parys as Chief Executive ...

Plasmid Purification Market to reach USD 6.6 Bn by 2035 at 12.3% CAGR, Driven by rising gene therapy demand, mRNA vaccines, ...

Dyadic International, Inc. ( DYAI) IAccess Alpha Virtual Best Ideas Winter Investment Conference 2025 December 9, 2025 9:30 AM EST Good day, and welcome to the iAcessAlpha Virtual Best Ideas winter ...